Bio-Techne faces near-term growth headwinds from challenges in academic and biotech research funding, but retains strong leverage to growing spatial biology, proteomics, and cell/gene therapy research ...

The DCF model implemented in this article suggests that Bio-Techne is overvalued by 34.53%. Bio-Techne has allocated significant financial resources to capex. Due to these resources, its revenues ...

TECHNE is a practice-based digital arts research initiative founded by Professor Mark Amerika, at the University of Colorado at Boulder. The TECHNE initiative develops innovative approaches to the ...

Bio-Techne Earnings: Strong Growth in Protein Sciences, but US Academic Market Uncertain Bio-Techne reported fiscal third-quarter organic revenue growth of 6% year on year, consisting of 7% organic ...